PALIVIZUMAB (pal i VI zu mab) is an antibody. It is used in infants and children to prevent severe cases of respiratory syncytial virus (RSV) infection. Children treated with this medicine may still get RSV but will not get as sick as if they were not treated at all. This medicine does not protect against other infections.
This medicine is for injection into a muscle. It is given by a health care professional in a hospital or clinic setting.
This drug may be prescribed for children as young as premature newborns. Talk to your doctor if you have any questions.
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
blue color to lips, skin
loss of appetite
fast, irregular heart beat
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
pain at site where injected
Interactions are not expected.
It is important not to miss a dose. Call your doctor or health care professional if you are unable to keep an appointment.
This drug is given in a hospital or clinic and will not be stored at home.
They need to know if your child has any of these conditions:
blood or bleeding disorders
immune system problems
an unusual or allergic reaction to palivizumab, vaccines or antibodies, other medicines, foods, dyes, or preservatives
See your health care provider for monthly injections of this medicine as directed.
NOTE:This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider. Copyright© 2017 Elsevier